168 related articles for article (PubMed ID: 36270332)
1. Protein A-Nanoluciferase fusion protein for generalized, sensitive detection of immunoglobulin G.
Nandy S; Crum M; Wasden K; Strych U; Goyal A; Maranholkar V; Mo W; Vu B; Kourentzi K; Willson RC
Anal Biochem; 2023 Jan; 660():114929. PubMed ID: 36270332
[TBL] [Abstract][Full Text] [Related]
2. A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies.
Solastie A; Virta C; Haveri A; Ekström N; Kantele A; Miettinen S; Lempainen J; Jalkanen P; Kakkola L; Dub T; Julkunen I; Melin M
Microbiol Spectr; 2021 Dec; 9(3):e0113121. PubMed ID: 34787485
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
[TBL] [Abstract][Full Text] [Related]
4. Single-step, wash-free digital immunoassay for rapid quantitative analysis of serological antibody against SARS-CoV-2 by photonic resonator absorption microscopy.
Zhao B; Che C; Wang W; Li N; Cunningham BT
Talanta; 2021 Apr; 225():122004. PubMed ID: 33592744
[TBL] [Abstract][Full Text] [Related]
5. Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals.
Egia-Mendikute L; Bosch A; Prieto-Fernández E; Lee SY; Jiménez-Lasheras B; García Del Río A; Antoñana-Vildosola A; Bruzzone C; Bizkarguenaga M; Embade N; Gil-Redondo R; Martínez-Chantar ML; López-Hoyos M; Abrescia NGA; Mato JM; Millet Ó; Palazón A
Commun Biol; 2021 Apr; 4(1):486. PubMed ID: 33879833
[TBL] [Abstract][Full Text] [Related]
6. A luciferase immunosorbent assay for quantitative detection of IgG antibodies against SARS-CoV-2 nucleoprotein.
Liang Y; Yan H; Huang L; Zhao J; Wang H; Kang M; Wan Z; Shui J; Tang S
J Virol Methods; 2021 Jun; 292():114141. PubMed ID: 33753172
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2.
Johnson M; Wagstaffe HR; Gilmour KC; Mai AL; Lewis J; Hunt A; Sirr J; Bengt C; Grandjean L; Goldblatt D
J Clin Virol; 2020 Sep; 130():104572. PubMed ID: 32769024
[TBL] [Abstract][Full Text] [Related]
8. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
[TBL] [Abstract][Full Text] [Related]
9. Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay.
Kang K; Huang L; Ouyang C; Du J; Yang B; Chi Y; He S; Ying L; Chen G; Wang J
J Med Virol; 2021 May; 93(5):2838-2847. PubMed ID: 33231312
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera.
Ha B; Jadhao S; Hussaini L; Gibson T; Stephens K; Salazar L; Ciric C; Taylor M; Rouphael N; Edupuganti S; Rostad CA; Tompkins SM; Anderson EJ; Anderson LJ
Microbiol Spectr; 2021 Oct; 9(2):e0045821. PubMed ID: 34494855
[TBL] [Abstract][Full Text] [Related]
11. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
den Hartog G; Schepp RM; Kuijer M; GeurtsvanKessel C; van Beek J; Rots N; Koopmans MPG; van der Klis FRM; van Binnendijk RS
J Infect Dis; 2020 Oct; 222(9):1452-1461. PubMed ID: 32766833
[TBL] [Abstract][Full Text] [Related]
13. Fcγ-Receptor-Based Enzyme-Linked Immunosorbent Assays for Sensitive, Specific, and Persistent Detection of Anti-SARS-CoV-2 Nucleocapsid Protein IgG Antibodies in Human Sera.
Deschermeier C; Ehmen C; von Possel R; Murawski C; Rushton B; Amuasi J; Sarpong N; Maiga-Ascofaré O; Rakotozandrindrainy R; Asogun D; Ighodalo Y; Oestereich L; Duraffour S; Pahlmann M; Emmerich P
J Clin Microbiol; 2022 Jun; 60(6):e0007522. PubMed ID: 35574677
[TBL] [Abstract][Full Text] [Related]
14. EDTA-K
Hu X; Wu C; Situ B; Tian P; An T; Li Q; Pan W; Zhang R; Yang B; Sun D; Hu Y; Wang Q; Zheng L
Int J Nanomedicine; 2021; 16():715-724. PubMed ID: 33542626
[TBL] [Abstract][Full Text] [Related]
15. Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samples.
Stubenrauch K; Wessels U; Essig U; Kowalewsky F; Vogel R; Heinrich J
J Pharm Biomed Anal; 2013 Jan; 72():208-15. PubMed ID: 23017233
[TBL] [Abstract][Full Text] [Related]
16. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs.
Van Elslande J; Decru B; Jonckheere S; Van Wijngaerden E; Houben E; Vandecandelaere P; Indevuyst C; Depypere M; Desmet S; André E; Van Ranst M; Lagrou K; Vermeersch P
Clin Microbiol Infect; 2020 Nov; 26(11):1557.e1-1557.e7. PubMed ID: 32745595
[TBL] [Abstract][Full Text] [Related]
17. Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay.
Chen Z; Zhang Z; Zhai X; Li Y; Lin L; Zhao H; Bian L; Li P; Yu L; Wu Y; Lin G
Anal Chem; 2020 May; 92(10):7226-7231. PubMed ID: 32323974
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
[TBL] [Abstract][Full Text] [Related]
19. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain.
Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K
J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of two SARS-CoV-2 IgG/IgM Rapid Tests in Capillary Blood Samples.
Lee NY; Ham JY; Hwang N; Song KE
Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
